FAST vs LAB · P/E 43, rev $7.55B vs rev $174.4M
Fastenal Company (FAST) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. LAB currently screens at market cap $317.1M.
Not investment advice. Open the FAST and LAB stock pages for the full models.
Not investment advice.